Francisco J. Olmo

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination.

Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination.

Journal: npj antimicrobials and resistance

Published: February 06, 2026

A Rapid Method for Purifying Intact Trypanosoma cruzi Amastigotes from Host Cells, In Vitro and In Vivo, for Downstream 'Omic Analysis.

A Rapid Method for Purifying Intact Trypanosoma cruzi Amastigotes from Host Cells, In Vitro and In Vivo, for Downstream 'Omic Analysis.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 03, 2025

Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection.

Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection.

Journal: Antimicrobial agents and chemotherapy

Published: May 07, 2025

Intermittent suppressive posaconazole therapy is ineffective at mitigating cardiac and digestive tract pathologies in an experimental model of chronic Chagas disease.

Intermittent suppressive posaconazole therapy is ineffective at mitigating cardiac and digestive tract pathologies in an experimental model of chronic Chagas disease.

Journal: Antimicrobial agents and chemotherapy

Published: May 05, 2025

Animal models for exploring Chagas disease pathogenesis and supporting drug discovery.

Animal models for exploring Chagas disease pathogenesis and supporting drug discovery.

Journal: Clinical microbiology reviews

Published: November 15, 2024

Cryo-EM led analysis of open and closed conformations of Chagas vaccine candidate TcPOP.

Cryo-EM led analysis of open and closed conformations of Chagas vaccine candidate TcPOP.

Journal: Nature communications

Published: March 26, 2024

A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research.

A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research.

Journal: PLoS neglected tropical diseases

Published: March 26, 2024

Bis-6-amidino-benzothiazole Derivative that Cures Experimental Stage 1 African Trypanosomiasis with a Single Dose.

Bis-6-amidino-benzothiazole Derivative that Cures Experimental Stage 1 African Trypanosomiasis with a Single Dose.

Journal: Journal of medicinal chemistry

Published: September 18, 2023

Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice.

Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice.

Journal: PLoS pathogens

Published: August 22, 2023

Dissecting the interstrand crosslink DNA repair system of Trypanosoma cruzi.

Dissecting the interstrand crosslink DNA repair system of Trypanosoma cruzi.

Journal: DNA repair

Published: January 17, 2023

Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi.

Image-Based In Vitro Screening Reveals the Trypanostatic Activity of Hydroxymethylnitrofurazone against Trypanosoma cruzi.

Journal: International journal of molecular sciences

Published: May 28, 2021

Design and synthesis of Mannich base-type derivatives containing imidazole and benzimidazole as lead compounds for drug discovery in Chagas Disease.

Design and synthesis of Mannich base-type derivatives containing imidazole and benzimidazole as lead compounds for drug discovery in Chagas Disease.

Journal: European journal of medicinal chemistry

Published: May 22, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026